Diagnostic evaluation of nonalcoholic fatty liver disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Gastroenterology

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.MCG.0000168642.38945.F1PMID 16540765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increasing prevalence of the metabolic syndrome among u.s. Adults.

  2004cited by this paper
• The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients

  2004cited by this paper
• Screening in liver disease: Report of an AASLD clinical workshop

  2004cited by this paper
• Beyond insulin resistance in NASH: TNF‐α or adiponectin?

  2004cited by this paper
• Long term prognosis of fatty liver: risk of chronic liver disease and death

  2004cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsies

  2004cited by this paper
• The Prevalence of Autoantibodies and Autoimmune Hepatitis in Patients with Nonalcoholic Fatty Liver Disease

  2004cited by this paper
• Prevalence and Significance of Autoantibodies in Patients With Non-Alcoholic Steatohepatitis

  2004cited by this paper
• Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

  2004cited by this paper
• Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

  2004cited by this paper
• Serum markers detect the presence of liver fibrosis: a cohort study.

  2004cited by this paper
• 715 Hyaluronic acid, an accurate serum marker for advanced fibrosis among nonalcoholic steatohepatitis

  2003cited by this paper
• Diagnosis of fatty liver disease: is biopsy necessary?

  2003influential reference
• Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates

  2003cited by this paper
• Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

  2003cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis.

  2003cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• The prevalence and etiology of elevated aminotransferase levels in the United States

  2003cited by this paper
• LETTER: Nonalcoholic Steatohepatitis-Related Cirrhosis with Subacute Liver Failure: An Autopsy Case

  2003cited by this paper
• Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation

  2002cited by this paper
• Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

  2002cited by this paper
• Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.

  2002cited by this paper
• Subacute liver failure in obese women

  2002cited by this paper
• American Gastroenterological Association medical position statement: evaluation of liver chemistry tests.

  2002cited by this paper
• HFE mutations, hepatic iron, and fibrosis: Ethnic‐specific association of NASH with C282Y but not with fibrotic severity

  2002cited by this paper
• The utility of radiological imaging in nonalcoholic fatty liver disease.

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.

  2001cited by this paper
• Test validity of periodic liver function tests in a population of Japanese male bank employees.

  2001cited by this paper
• Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

  2000cited by this paper
• Liver fibrosis in overweight patients.

  2000cited by this paper
• An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities

  2000cited by this paper
• Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study

  2000influential reference
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999influential reference
• Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

  1999cited by this paper
• Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

  1999influential reference
• The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Association of nonalcoholic fatty liver disease with insulin resistance.

  1999cited by this paper
• Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

  1998cited by this paper
• Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload.

  1998cited by this paper
• Two cases from the spectrum of nonalcoholic steatohepatitis.

  1995cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.

  1991cited by this paper
• Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.

  1991cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990influential reference
• Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

  1989cited by this paper
• Prevalence of fatty liver in a general population of Okinawa, Japan.

  1988cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper

• The Unexpected Detection of Esophageal Varices Caused by Liver Cirrhosis in a 47-Year-Old Man Treated with a Growth Hormone in Childhood

  2024cites this paper
• Gamma-glutamyltransferase (GGT) is a predictor of NAFLD activity score for diagnosing non- alcoholic steatohepatitis (NASH)

  2024cites this paper
• Comparison of laparoscopic evaluation of hepatosteatosis with ultrasound findings.

  2023cites this paper
• Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study

  2023cites this paper
• Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss

  2022cites this paper
• Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques

  2022influential citation
• Evaluation Through the Optical Coherence Tomography Analysis of the Influence of Non-Alcoholic Fatty Liver Disease on the Gingival Inflammation in Periodontal Patients

  2021cites this paper
• DMSO_A_310314 2935..2942

  2021cites this paper
• Non-Alcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?

  2020cites this paper
• International Journal of Current Science and Multidisciplinary Research

  2020cites this paper
• Biochemistry of Non Infectious Hepatitis - A Review

  2020cites this paper
• Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index.

  2020cites this paper
• The Role of Elastography in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Association between serum ferritin and non-alcoholic fatty liver disease among middle-aged and elderly Chinese with normal weight.

  2019cites this paper
• Alanine Aminotransferase is a Predictor of NAFLD Activity Score for Diagnosing Non-alcoholic Steatoehpatitis

  2019cites this paper
• Aspartate Aminotransferase (AST) is a good Predictor of NAFLD Activity Score (NAS) for Diagnosing Non- alcoholic Steatohepatitis (NASH)

  2019cites this paper
• The HAALT Non-invasive Scoring System for NAFLD in Obesity

  2019cites this paper
• Prevalence and risk factors of non‐alcoholic fatty liver disease in Bangladesh

  2018cites this paper
• Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups

  2018cites this paper
• Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis.

  2018cites this paper
• The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver

  2017cites this paper
• Effect of pentoxifylline on histological activity and fibrosis of nonalcoholic steatohepatitis patients: A one year randomized control trial

  2017cites this paper
• Histopathological Studies on Fatty Liver Disease

  2017cites this paper
• Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease

  2016cites this paper
• Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis

  2016cites this paper
• Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study

  2016cites this paper
• Revisión Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease

  2015cites this paper
• Ultrasound-based tissue characterization and classification of fatty liver disease

  2015cites this paper
• Prevalence of non- alcoholic fatty liver disease among type-2 diabetes mellitus patients - A cross-sectional hospital based study

  2015cites this paper
• Структурные изменения в тимусе крыс после воздействия экспериментальной гипертермии

  2015cites this paper
• Readiness for behaviour change in non‐alcoholic fatty liver disease: implications for multidisciplinary care models

  2015cites this paper
• Ruolo del gene PNPLA3 nella suscettibilità genetica della steatosi epatica non alcolica

  2015cites this paper
• Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees

  2015cites this paper
• Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women

  2014cites this paper
• Effect of treatment with oral red propolis extract on nonalcoholic teatohepatitis

  2014cites this paper
• Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease.

  2014cites this paper
• Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes.

  2014cites this paper
• Nonalcoholic fatty liver disease and polycystic ovary syndrome.

  2014cites this paper
• Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.

  2014cites this paper
• Protective effects of Spirulina on the liver function and hyperlipidemia of rats and human

  2014cites this paper
• Association between polycystic ovary syndrome and metabolic syndrome.

  2014cites this paper
• MTCBP-1 Protein Expression is Enhanced in Fat Overloaded HepG2

  2014cites this paper
• Nonalcoholic fatty liver disease in patients with morbid obesity

  2013cites this paper
• Early detection of liver steatosis by magnetic resonance imaging in rats infused with glucose and intralipid solutions and correlation to insulin levels.

  2013cites this paper
• Relationship between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Adult Males, South China

  2013cites this paper
• Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.

  2013cites this paper
• Avaliação dos marcadores clínicos e inflamatórios da doença hepática gordurosa não alcoólica em mulheres na pós-menopausa com síndrome metabólica

  2013cites this paper
• Avaliação da doença hepática gordurosa não alcoólica em mulheres na pós-menopausa

  2013cites this paper
• Non-Alcoholic Fatty Liver Disease: From patient to population

  2013cites this paper
• Prognostic factors for progression of simple steatosis to steatohepatitis in patients with persistent normal and elevated liver enzymes

  2013cites this paper
• A Case of Nonalcoholic Steatohepatitis and Small Intestinal Bacterial Overgrowth with Peripheral Edema Caused by Intestinal Bypass Surgery and Relieved by Repair

  2012cites this paper
• 2 Histopathological Diagnosis of Non-Alcoholic and Alcoholic Fatty Liver Disease

  2012cites this paper
• Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.

  2012cites this paper
• Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease.

  2012cites this paper
• Differential diagnosis of focal hepatic lesions

  2012cites this paper
• Nonalcoholic fatty liver disease and lipids

  2012cites this paper
• Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver.

  2012cites this paper
• Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study.

  2012cites this paper
• Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.

  2012cites this paper
• Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.

  2012cites this paper
• Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?

  2012cites this paper
• NONALCOHOLIC FATTY HEPATIC DISEASE: RELEVANCE OF THE DIAGNOSIS ON ABDOMINAL ULTRASOUND

  2011cites this paper
• Psoriasis and non‐alcoholic fatty liver disease

  2011cites this paper
• Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease

  2011cites this paper
• Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis

  2011cites this paper
• Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.

  2011cites this paper
• New clinical score to diagnose nonalcoholic steatohepatitis in obese patients

  2011influential citation
• Doença hepática gordurosa não-alcoólica: importância da ultra-sonografia abdominal no diagnóstico

  2011cites this paper
• [Guidelines for the prevention, diagnosis and treatment of obesity].

  2011cites this paper
• The diagnosis of nonalcoholic fatty liver disease

  2010cites this paper
• Histopathologische Diagnose der nichtalkoholischen und alkoholischen Fettlebererkrankung

  2010cites this paper
• Histopathologische Diagnose der nicht alkoholischen und alkoholischen Fettlebererkrankung

  2010cites this paper
• La steatosi epatica non alcolica: una nuova insidia per il cardiologo

  2010cites this paper
• Optimum imaging of colorectal metastases

  2010cites this paper
• Histopathologische Diagnose der nicht alkoholischen und alkoholischen Fettlebererkrankung

  2010cites this paper
• Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study

  2010cites this paper
• Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

  2010cites this paper
• [Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines].

  2010cites this paper
• [Diagnosis and management of non alcoholic fatty liver disease].

  2009cites this paper
• Gastrointestinal Manifestations of Diabetes Mellitus: Spectrum of Imaging Findings

  2009cites this paper
• Diagnosis and management of non alcoholic fatty liver disease

  2009cites this paper
• The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity

  2009cites this paper
• Non-alcoholic steatohepatitis: an overview.

  2009cites this paper
• Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography.

  2009cites this paper
• Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.

  2009cites this paper
• New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)

  2009cites this paper
• Nonviral Hepatitis

  2009influential citation
• Non alcoholic fatty liver disease and metabolic syndrome.

  2009cites this paper
• Review article: diagnosis and treatment of non‐alcoholic fatty liver disease

  2008cites this paper
• A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

  2008cites this paper
• Anti-HCV reactive blood donors: clinical and epidemiological factors associated with false-reactive results

  2008cites this paper
• Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

  2008cites this paper
• Esteatosis hepática no alcohólica. Puesta al día

  2008cites this paper
• [Non-alcoholic hepatic steatosis. An update].

  2008cites this paper
• Anti‐hepatitis C virus‐positive blood donors: are women any different?

  2008cites this paper
• Visceral adipose tissue area is an independent risk factor for hepatic steatosis

  2008cites this paper
• Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

  2008cites this paper
• Evolving trends in nonalcoholic fatty liver disease.

  2008cites this paper
• Treating nonalcoholic fatty liver disease

  2007cites this paper
• Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

  2007cites this paper